|
HS Code |
906583 |
As an accredited 8-Bromo-5-Fluoroquinoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 8-Bromo-5-Fluoroquinoline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Over the last two decades, specialty quinoline compounds have reshaped research and industrial chemistry, giving scientists new building blocks to unlock complex molecules and more sustainable processes. Among these compounds, 8-Bromo-5-Fluoroquinoline stands out for its clever fusion of halogen functionality with the robust backbone of quinoline. For those in pharmaceuticals, agrochemicals, or advanced materials, this compound doesn't just expand a toolkit, it opens new possibilities.
Chemists will notice right away how the bromine atom at position 8 and the fluorine atom at position 5 each change the electronic character of the quinoline ring. That simple act of swapping in halogens makes the compound more reactive at predictable points—especially useful in cross-coupling reactions, where efficiency, precision, and orthogonality matter. The compound walks into the lab as a pale to off-white solid, holding a molecular formula of C9H5BrFN, bringing a calculated molecular weight that fits well in a growing library of halogenated heterocycles. Compared to its cousins like plain quinoline or mono-halogenated types, giving chemists two easy handles—bromine and fluorine—lets them plan syntheses with much more flexibility.
Experience tells me that not every building block has what it takes to move from the notebook to real-world impact. There’s plenty of theory on cross-coupling or on-site functionalization, but in practice, many so-called useful reagents fizzle out when purity, consistency, and specific reactivity come into play. 8-Bromo-5-Fluoroquinoline, in contrast, has met or exceeded expectations across several projects. Its performance in Suzuki and Heck-type reactions rivals that of classic 8-bromoquinolines, while the added fluorine keeps things interesting when tuning molecule polarity or tweaking metabolic stability in a drug candidate. That double halogen substitution also helps with late-stage diversification, a must in medicinal chemistry when SAR (structure-activity relationship) loops run fast.
Let’s drill into how 8-Bromo-5-Fluoroquinoline turns heads in research and manufacturing environments. In my own work, this compound is a go-to for N-arylation and C–C bond-forming steps that benefit from its unique balance of electronic and steric effects. The bromine sits at a reactive site for palladium catalysis—a proven move for building up larger heterocyclic libraries. Fluorine, subtle as it may be, tweaks electron density, often yielding higher selectivity in aromatic substitutions or streamlining late-stage fluorination, a prized feature when pushing for improved pharmacokinetic or agrochemical outcomes.
In pharmaceutical development, regulatory authorities keep an eagle eye on manufacturing routes, intermediates, and impurity profiles. Here, 8-Bromo-5-Fluoroquinoline makes process optimization easier. That extra fluorine tends to lower metabolic vulnerability, which can translate into more promising drug candidates with longer half-lives or lower off-target effects. Instead of producing multiple mono-halogenated intermediates and testing each one, teams can use this dual-substituted version to run parallel synthesis, cutting time-to-results and supporting faster scale-up.
Many chemists ask why they should reach for 8-Bromo-5-Fluoroquinoline over the simple unsubstituted skeleton, or more common halogenated derivatives like 8-bromoquinoline or 5-fluoroquinoline alone. The answer sits in real performance, not just theory. The bromine group offers high-yield cross-couplings, but the addition of fluorine unlocks different polarity, altered hydrogen-bonding, and greater control over what gets metabolized or transformed during downstream reactions. This combination trumps single-substituted versions when designing molecules with tailored distribution, targeting, or safety characteristics—a fact supported by both the academic literature and my own test bench.
In contrast, using mono-bromo or mono-fluoro versions often means extra steps, more purification, or a shot-in-the-dark approach to tuning properties. The blended approach makes it easier to pursue green chemistry, too: faster, fewer steps means less solvent and waste—a growing priority both for cost and environmental regulations.
Quality cannot be taken for granted, especially if the compound is heading for pilot or production scale rather than a single experiment. The best suppliers provide 8-Bromo-5-Fluoroquinoline at high purity, typically exceeding 98%, and in packaging options suitable for research or larger batches. Analytical profiles, including NMR and HPLC traces, consistently match claims, which is a reassuring sign for both process optimization and meeting regulatory scrutiny. Based on my work, reproducibility and shelf-stability put it solidly ahead of more delicate or impurity-laden building blocks.
For any industrial process, regulatory compliance and sustainability aren’t just buzzwords. The dual halogenation in 8-Bromo-5-Fluoroquinoline fits well with emerging guidelines for risk assessment and impurity tracking, especially in pharmaceutical or agrichem sectors. Brominated and fluorinated intermediates get watched closely for persistence and environmental fate. My teams have found that this compound often lets us skip more hazardous steps, such as harsh reagents or multi-stage halogenation, which in turn reduces the burden of waste handling and the risk profile of a process. Reducing pipeline hazards pays off in workers' safety and in smooth auditing, especially as authorities in Europe and North America step up enforcement.
Every chemist looks for reliability and predictability. In medicinal chemistry, structure is often tweaked at late stages to fine-tune receptor binding, solubility, or metabolic stability. Here, 8-Bromo-5-Fluoroquinoline stands out because both handles—the bromine and fluorine positions—provide clear, distinct points for chemical elaboration. For example, Suzuki couplings at the 8-position can introduce bioisosteres or larger aromatic rings, while the 5-fluoro group lets you probe SAR without worrying about metabolic dehalogenation—a classic pitfall for mono-brominated analogs.
Other research fields benefit as well. Agrochemical discovery now demands rapid-turnaround analog series where subtle electronic shifts can make or break crop safety or pest selectivity. This compound enables that kind of quick pivoting, saving not just time but also budget lines as it yields more successful candidates with fewer dead ends.
There’s a noticeable difference when using well-prepared 8-Bromo-5-Fluoroquinoline. Fewer side products appear. Scale-up from milligram to multi-gram quantities happens without discovering new "gremlins" along the way. Colleagues have pointed out that the reproducibility from batch to batch holds up, which is not always the case with bespoke or less well-characterized reagents. This reliability encourages process chemists to treat it as a mainstay, not a specialty option.
The main pain point usually emerges only when cutting corners on source or quality—impurities creeping in, or supply interruptions on larger orders. These are logistical headaches, not inherent chemistry flaws, but point to the need for strong supplier relationships. Trust, in this case, is backed up by analytical transparency and long-term consistency over dozens of runs or pilot campaigns.
Translating a promising molecule from the bench to kilo-scale involves more than mixing and heating. 8-Bromo-5-Fluoroquinoline fits well into existing unit operations with standard solvents and reaction conditions. Its melting point and solubility profile work for both manual and automated setups, and handling protocols match what most facilities already know from dealing with halogenated aromatics. This feature avoids nasty surprises during scale up, a common stumbling block for less robust building blocks.
Pharmaceutical and agrochemical manufacturers have come to rely on dual-halogenated intermediates for both diversity-oriented synthesis and for anchoring patentable claims. My review of both internal documentation and open literature shows multiple successful campaigns on this backbone, including in late-phase route scouting and early lead optimization.
While few compounds are without challenges, 8-Bromo-5-Fluoroquinoline has mostly manageable ones. If yield suffers or batch color shifts occur, investigation almost always leads back to storage, supplier purity, or changes in solvent quality. Implementing rigorous incoming material checks, along with proper storage away from light and moisture, overcomes most problems. Partnering with reputable firms willing to provide analytical data ensures steady operation.
Those seeking to push reactivity further sometimes run up against limits in extreme transformations or multi-step cascades. Here, combining the use of additives or ligand-optimized catalysts can coax optimal performance. Each time we've tested different ligand sets, especially ones tailored for heterocycles, small leaps in yield or regioselectivity often result—suggesting there's room for fine-tuning even with a strong performer. Documenting these optimizations and sharing insights between internal teams helps not just on individual projects, but in building a knowledge base for future generations of chemists.
Looking at chemical manufacturing as a whole, adaptability and sustainability increasingly drive decision-making. With growing customer and regulatory pressures, using fewer, more versatile building blocks matters. 8-Bromo-5-Fluoroquinoline fits this goal: it accelerates discovery and reduces waste. Its dual-functionalized nature means chemists handle fewer unique chemicals, store less, and gain more from each synthetic route.
From another angle, risk management teams like the reduced likelihood of off-pathway side reactions. As global supply chain disruptions drag on, compounds that play well with multiple reaction types help buffer projects from single-point failures. In my group's experience, being able to design routes that swap out downstream partners using the same quinoline core increases project resilience, whether the goal is a new fungicide or a first-in-class therapeutic.
Environmental stewardship no longer sits on the edge of the research agenda. Many organizations now report regularly on waste volumes, GHG emissions, and even solvent recycling rates. Bench chemistry only scales well when the entire route supports reduction, reuse, and substitution for hazardous inputs. 8-Bromo-5-Fluoroquinoline often feeds into routes that eliminate extra halogenation or harsh reagents. Its efficiency at key steps supports measurable savings—less solvent, energy, and off-gassing—making it a logical fit for sustainability-minded programs.
In effect, choosing this compound signals a willingness to invest in longer-term success rather than chasing lowest-dollar options with questionable sourcing or unknown impacts. This approach tends to win support at higher corporate levels when the compliance, finance, and safety teams weigh in.
The pace of innovation picks up every year, and chemists look for ways to outpace competing firms and publish first. In this climate, reagents like 8-Bromo-5-Fluoroquinoline become crucial. The compound slides into not only cross-coupling but also suites of newer transformations—click reactions, C–H activation, or photoredox catalysis—where versatility and predictable reactivity make an outsized difference. I’ve seen wave after wave of advance sparked by just such building blocks, where a small change in substitution pattern leads to a leap in biological activity or processing advantage.
On a practical note, the broader adoption of high-throughput and automated synthesis platforms also favors compounds with clean, predictable profiles. 8-Bromo-5-Fluoroquinoline, with its solid-state stability, straightforward handling, and broad compatibility, means fewer hiccups when deploying robotics or automated purification pathways. Organizations aiming to boost productivity will appreciate this benefit over time.
Having worked alongside both academic and industry partners, the importance of quality, reliability, and adaptability has become crystal clear. 8-Bromo-5-Fluoroquinoline meets these needs—it acts as a keystone for both routine and exploratory chemistry, especially where deadlines and stakes run high. It helps bridge the gap between small-scale R&D and larger-scale application, reducing friction at each step.
I have seen firsthand the impact of switching from more generic intermediates to this compound, from boost in yields to fewer headaches when it comes to purification and by-product management. That level of improvement passes on not just cost and time savings, but also encourages more aggressive timelines for launch or patent filings—critical advantages in today’s fast-changing markets.
Comparing many options in the world of quinoline chemistry, 8-Bromo-5-Fluoroquinoline rises above ankle-biter intermediates and flavor-of-the-month reagents. Its dual reactivity, clean analytical signatures, and broad compatibility make it more than just another chemical on the shelf. As chemistry and industry needs continue evolving, placing trust in reliable, well-characterized intermediates like this one forms part of building a successful, responsible, and competitive research pipeline. Entering projects with the right tools helps not only the science, but also the teams who keep those projects alive—and that's a value any researcher, manager, or manufacturer can appreciate.